Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from OrganiGram Holdings ( (TSE:OGI) ) is now available.
Organigram Global Inc. announced on December 5, 2025, that it will release its fourth quarter fiscal 2025 earnings results on December 16, 2025. The company will host a conference call to discuss the results, which could impact its market positioning and stakeholder interests, given its status as Canada’s top cannabis company by market share.
The most recent analyst rating on (TSE:OGI) stock is a Hold with a C$2.50 price target. To see the full list of analyst forecasts on OrganiGram Holdings stock, see the TSE:OGI Stock Forecast page.
Spark’s Take on TSE:OGI Stock
According to Spark, TipRanks’ AI Analyst, TSE:OGI is a Neutral.
OrganiGram Holdings’ overall score reflects strong earnings performance and market position, offset by technical weakness and valuation concerns. The company’s financial performance shows potential, but cash flow management needs improvement. The positive sentiment from the earnings call suggests a promising long-term trajectory, despite current challenges.
To see Spark’s full report on TSE:OGI stock, click here.
More about OrganiGram Holdings
Organigram Global Inc. is a leading cannabis company in Canada, listed on NASDAQ and TSX. It focuses on producing high-quality cannabis for adult recreational use and expanding its global footprint through international partnerships. The company has a diverse portfolio of cannabis brands and operates multiple facilities in Canada, including those optimized for edibles manufacturing and cannabinoid processing.
Average Trading Volume: 186,353
Technical Sentiment Signal: Buy
Current Market Cap: C$307.6M
For a thorough assessment of OGI stock, go to TipRanks’ Stock Analysis page.